• Ypsomed reported first-half 2026/27 net profit of CHF 85.5 million, while Group EBIT fell 34% to CHF 99.8 million.
• Group sales dropped 12% to CHF 317.6 million, reflecting the divestments of Diabetes Care and Ypsotec.
• Delivery Systems sales climbed 18% to CHF 286.6 million, with a record 30 new customer projects won.
• Raised 2026/27 Delivery Systems guidance targets sales growth of 13%-16% and EBIT of CHF 220 million to CHF 240 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ypsomed Holding AG published the original content used to generate this news brief on November 11, 2026, and is solely responsible for the information contained therein.